At Diet UK, we are committed to offering safe, clinically supported weight-management treatment tailored to individual needs. As childhood obesity continues to rise, the health and wellbeing of adolescents aged 12 to 17 years is becoming an urgent focus. Wegovy (semaglutide), now approved for weight management in this age group, offers a valuable treatment pathway for those with obesity who have not responded to lifestyle changes alone.
Backed by strong clinical evidence, Wegovy provides more than a means to reduce weight. It can play a significant role in supporting long-term health in adolescents facing the complex challenges of obesity.
Obesity in Adolescents: A Serious Health Concern
Obesity is now recognised as a disease by leading authorities such as the Centers for Disease Control and Prevention (CDC). It affects people across all age groups, including adolescents, and its impact can extend well into adulthood. Children and teenagers with obesity are more likely to develop conditions such as high blood pressure, insulin resistance, joint pain, breathing difficulties, and mental health concerns like low self-esteem or depression.
Obesity in young people is medically defined using the body mass index (BMI). For adolescents, obesity is diagnosed when BMI is at or above the 95th percentile for their age and sex, based on growth charts. Health care professionals use this screening tool to monitor changes in weight and identify when medical intervention may be necessary.
At Diet UK, we take this definition seriously and use it as a basis for thorough assessments, ensuring any treatment is evidence-led, appropriate, and tailored to the individual.
What Is Wegovy and How Does It Work?
Wegovy (semaglutide) is a once-weekly injectable medication that works by mimicking the GLP-1 hormone. This hormone helps regulate appetite and food intake, contributing to a reduced desire to eat and improved portion control. In adolescents, as in adults, this mechanism can assist with weight reduction when used alongside a structured lifestyle plan.
However, Wegovy is not simply about weight loss. By helping regulate blood sugar levels, reduce inflammation, and promote healthier metabolic function, it supports broader improvements in health. These changes are especially important for adolescents, whose bodies are still developing.
Clinical Evidence: How Wegovy Performed in Adolescents
Wegovy was studied in a large-scale medical trial involving adolescents with obesity, aged 12 to 17. The study spanned a total of 68 weeks, with all participants first undergoing a 12-week period of behavioural lifestyle therapy, including nutritional counselling and physical activity guidance. Following this, participants were randomly assigned to two groups: one received Wegovy and the other received a placebo (an inactive treatment). All continued lifestyle therapy throughout the trial.
The results were compelling. Adolescents treated with Wegovy experienced significantly greater reductions in body weight compared to those in the placebo group. Many saw improvements in waist circumference, blood pressure, and blood sugar levels – key indicators of metabolic health. These findings confirm that when used as part of a medically supervised plan, Wegovy can be a safe and effective weight-management tool for this age group.
Who May Benefit from Wegovy?
Wegovy is approved for adolescents aged 12 to 17 who:
- Have a BMI at or above the 95th percentile for their age and sex, classifying them as obese
- Have previously tried lifestyle-based approaches (dietary changes, increased physical activity, counselling) without adequate success
- Are experiencing or are at risk of obesity-related health conditions, such as prediabetes, high blood pressure, or abnormal cholesterol levels
- Require a structured, medical approach to manage their weight safely
Treatment with Wegovy should only be initiated under the guidance of a qualified medical professional as part of a holistic, supervised care programme.
A Comprehensive Approach: More Than a Prescription
At Diet UK, we understand that adolescent obesity cannot be addressed with medication alone. Our support programmes are designed to provide young people with the tools they need to succeed in the long term. This includes:
- Medical Oversight – Our doctors assess eligibility, monitor safety, and adjust the treatment plan as needed.
- Nutrition Advice – Practical, age-appropriate guidance is provided to help adolescents and their families make healthier food choices.
- Lifestyle Coaching – Support extends to goal setting, physical activity planning, and addressing emotional eating patterns, often in collaboration with behavioural specialists.
- Family Involvement – Parents and caregivers are included in the management to help reinforce healthy behaviours at home and improve long-term outcomes.
Our team works closely with families to build confidence and empower adolescents to take control of their health in a supportive, non-judgemental environment.
How Is Treatment Monitored?
Adolescents starting Wegovy typically begin with a low dose that is gradually increased to reduce the risk of side effects such as nausea or stomach discomfort. Throughout the course of treatment, regular follow-up appointments are scheduled to monitor progress and adjust the care plan accordingly.
Mental and emotional wellbeing is also assessed regularly, as we recognise the strong link between obesity and psychological health, especially in teenagers.
Why Early Intervention Matters
Obesity during adolescence can have lasting effects on physical and emotional development. Without intervention, it often continues into adulthood, where the risk of developing chronic diseases increases significantly. Early medical support can help change that trajectory.
When addressed in the teenage years, obesity is more responsive to change. With support, adolescents are more likely to achieve and maintain a healthy weight, adopt lifelong habits that reduce disease risk, and improve their quality of life.
Start the Journey Towards Better Health
If your child is struggling with obesity and previous lifestyle-based efforts have not led to meaningful progress, Wegovy can offer appetite control to support weight loss. At Diet UK, we take a careful, individualised approach to determine if this treatment is suitable, and we provide the medical oversight necessary for safe and effective use.
Our goal is to help adolescents move towards a healthier future — not just through weight loss, but through improved wellbeing, greater confidence, and long-term habit change.
To find out more or to book a consultation, get in touch with our team today. We’re here to support families every step of the way.